| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $0.7B | $1.0B | $7.8B | $7.2B | $1.6B | $1.9B | $1.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | $0.1B | $0.2B | — | — | $0.3B | $0.5B | $0.4B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.3B | $0.3B |
| SG&A Expense | $0.5B | $0.5B | $0.7B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B |
| Operating Income | $0.0B | $0.0B | $-0.1B | $0.5B | $0.5B | $-0.1B | $0.2B | $0.1B |
| Net Income | $0.1B | $1.0B | $-0.4B | $0.1B | $0.1B | $-0.1B | $0.3B | $-0.1B |
| EPS (Basic) | $0.30 | $-0.10 | $-2.28 | $0.32 | $0.62 | $-1.62 | $2.69 | $-0.51 |
| EPS (Diluted) | $0.30 | $-0.10 | $-2.28 | $0.31 | $0.58 | $-1.62 | $2.43 | $-0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.9B | $4.5B | $5.0B | $11.5B | $11.6B | $8.4B | $9.0B | $7.8B |
| Current Assets | $1.1B | $1.7B | $1.2B | $3.1B | $2.9B | $2.5B | $3.1B | $3.0B |
| Cash & Equivalents | $0.2B | $0.7B | $0.3B | $0.5B | $0.4B | $0.3B | $0.5B | $0.5B |
| Total Liabilities | $2.8B | $3.2B | $4.7B | $9.8B | $10.1B | $7.1B | $7.5B | $6.5B |
| Current Liabilities | $1.1B | $1.4B | $1.3B | $2.7B | $2.8B | $2.1B | $2.5B | $2.3B |
| Stockholders' Equity | $0.9B | $0.9B | $0.0B | $1.5B | $1.3B | $1.0B | $1.1B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $-0.1B | $0.7B | $0.4B | $1.1B | $0.6B | $0.6B | — |
| Investing Cash Flow | $-0.1B | $2.2B | $-0.3B | $-0.4B | $-2.8B | $-0.3B | $-0.5B | — |
| Capital Expenditures | — | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $-1.6B | $-0.8B | $0.0B | $2.2B | $-0.5B | $-0.0B | — |